• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图引导下经皮心肌内间隔射频消融术并发症的危险因素分析

Analysis of risk factors for complications in echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation.

作者信息

Wang Hanzhi, Cheng Jifang, Chen Qi, Pu Zhaoxia, Li Huajun

机构信息

Department of Nursing, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.

出版信息

J Cardiothorac Surg. 2024 Jul 16;19(1):454. doi: 10.1186/s13019-024-02934-1.

DOI:10.1186/s13019-024-02934-1
PMID:39014445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11251329/
Abstract

BACKGROUND

The feasibility of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) for the treatment of hypertrophic obstructive cardiomyopathy (HOCM) has been previously reported. However, limited investigation has been conducted regarding the complications associated with this procedure.

OBJECTIVE

This study aims to analyze the risk factors affecting the occurrence of complications during PIMSRA, such as pericardial effusion, ventricular premature beats, and interventricular septal perforation. In this study, the optimal cut-off values for these risk factors are also explored, and corresponding strategies for prevention are proposed.

METHODS

A total of 101 patients diagnosed with HOCM who underwent the PIMSRA procedure from 2021 to 2022 were included in this retrospective analysis. Patients were classified into subgroups with or without complications based on procedural records. Univariate and multivariate regression analyses were conducted to identify independent risk factors for complications during the PIMSRA procedure.

RESULTS

There were 48 patients with complications and 53 patients without complications. The heart rate at the start of the procedure and the maximum left ventricular outflow tract gradient (LVOTG) were independent risk factors related to PIMSRA complications. The optimal cut-off values for predicting complication occurrence were a heart rate > 49 bpm at the start of the procedure (OR: 3.79, 95% CI: 1.64-8.78, p = 0.002) and a maximum LVOTG > 92 mmHg (OR: 2.57, 95% CI: 1.15-5.75, p = 0.022), respectively.

CONCLUSIONS

The occurrence of PIMSRA complications is primarily associated with the heart rate at the start of the procedure and the maximum LVOTG. It is recommended to establish a comprehensive control plan to minimize the risk of complications during PIMSRA procedures.

摘要

背景

经皮心肌间隔射频消融术(PIMSRA)治疗肥厚性梗阻性心肌病(HOCM)的可行性此前已有报道。然而,关于该手术相关并发症的研究较少。

目的

本研究旨在分析影响PIMSRA手术期间并发症发生的危险因素,如心包积液、室性早搏和室间隔穿孔。本研究还探讨了这些危险因素的最佳截断值,并提出了相应的预防策略。

方法

本回顾性分析纳入了2021年至2022年期间接受PIMSRA手术的101例确诊为HOCM的患者。根据手术记录将患者分为有并发症和无并发症的亚组。进行单因素和多因素回归分析,以确定PIMSRA手术期间并发症的独立危险因素。

结果

48例患者出现并发症,53例患者未出现并发症。手术开始时的心率和最大左心室流出道梯度(LVOTG)是与PIMSRA并发症相关的独立危险因素。预测并发症发生的最佳截断值分别为手术开始时心率>49次/分(OR:3.79,95%CI:1.64-8.78,p=0.002)和最大LVOTG>92 mmHg(OR:2.57,95%CI:1.15-5.75,p=0.022)。

结论

PIMSRA并发症的发生主要与手术开始时的心率和最大LVOTG有关。建议制定全面的控制计划,以降低PIMSRA手术期间并发症的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8147/11251329/c00252bdbd0c/13019_2024_2934_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8147/11251329/43431ea2cc69/13019_2024_2934_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8147/11251329/c00252bdbd0c/13019_2024_2934_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8147/11251329/43431ea2cc69/13019_2024_2934_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8147/11251329/c00252bdbd0c/13019_2024_2934_Fig2_HTML.jpg

相似文献

1
Analysis of risk factors for complications in echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation.超声心动图引导下经皮心肌内间隔射频消融术并发症的危险因素分析
J Cardiothorac Surg. 2024 Jul 16;19(1):454. doi: 10.1186/s13019-024-02934-1.
2
Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.梗阻性肥厚型心肌病经皮心内间隔射频消融术后心肌灌注改善及机制:心肌对比超声心动图研究
Int J Cardiovasc Imaging. 2024 Jul;40(7):1483-1492. doi: 10.1007/s10554-024-03126-7. Epub 2024 May 6.
3
Midterm Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy: A Single-Center, Observational Study.经皮心肌内射频消融治疗肥厚型心肌病的中期结果:单中心观察性研究。
J Am Heart Assoc. 2024 Aug 6;13(15):e034080. doi: 10.1161/JAHA.123.034080. Epub 2024 Jul 26.
4
[Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].经胸超声心动图引导下经皮心肌间隔射频消融术治疗梗阻性肥厚型心肌病患者的疗效与安全性
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Apr 24;47(4):284-290. doi: 10.3760/cma.j.issn.0253-3758.2019.04.005.
5
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.经皮心肌内室间隔射频消融治疗药物难治性肥厚梗阻性心肌病。
JAMA Cardiol. 2022 May 1;7(5):529-538. doi: 10.1001/jamacardio.2022.0259.
6
Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation.经皮心内膜间隔射频消融术的心肌力学
Heart. 2023 Jan 27;109(4):289-296. doi: 10.1136/heartjnl-2022-321597.
7
Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.经皮心肌内室间隔射频消融治疗肥厚型梗阻性心肌病。
J Am Coll Cardiol. 2018 Oct 16;72(16):1898-1909. doi: 10.1016/j.jacc.2018.07.080.
8
Short time effects of two radiofrequency ablation methods on hypertrophic obstructive cardiomyopathy.两种射频消融方法对肥厚型梗阻性心肌病的短期疗效。
Clin Cardiol. 2024 Feb;47(3):e24217. doi: 10.1002/clc.24217.
9
A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.一种用于肥厚性梗阻性心肌病中射频导管消融间隔肥厚的新方法。
Indian Heart J. 2016 Sep-Oct;68(5):618-623. doi: 10.1016/j.ihj.2016.02.007. Epub 2016 Apr 14.
10
Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.经皮心肌内间隔射频消融术后 5 年随访。
Heart. 2024 May 10;110(11):792-799. doi: 10.1136/heartjnl-2023-323606.

本文引用的文献

1
Two severe complications post-percutaneous intramyocardial septal radiofrequency ablation in a patient with failed alcohol septal ablation: pulseless electrical activity cardiac arrest and pericardial tamponade-a case report.酒精性室间隔消融失败患者经皮心肌内室间隔射频消融术后的两种严重并发症:无脉电活动心脏骤停和心包填塞——病例报告
Eur Heart J Case Rep. 2023 Aug 7;7(8):ytad371. doi: 10.1093/ehjcr/ytad371. eCollection 2023 Aug.
2
First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy.Liwen RF™消融系统首次应用于人体治疗药物难治性肥厚性梗阻性心肌病。
Front Cardiovasc Med. 2022 Nov 9;9:1028763. doi: 10.3389/fcvm.2022.1028763. eCollection 2022.
3
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.经皮心肌内室间隔射频消融治疗药物难治性肥厚梗阻性心肌病。
JAMA Cardiol. 2022 May 1;7(5):529-538. doi: 10.1001/jamacardio.2022.0259.
4
Prognostic impact of mean heart rate by Holter monitoring on long-term outcome in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.动态心电图监测平均心率对经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者长期预后的影响。
Clin Res Cardiol. 2021 Sep;110(9):1439-1449. doi: 10.1007/s00392-021-01806-1. Epub 2021 Feb 6.
5
Ivabradine in Cardiovascular Disease Management Revisited: a Review.伊伐布雷定在心血管疾病管理中的再评价:一篇综述。
Cardiovasc Drugs Ther. 2021 Oct;35(5):1045-1056. doi: 10.1007/s10557-020-07124-4. Epub 2021 Jan 7.
6
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020年美国心脏协会/美国心脏病学会肥厚型心肌病患者诊断和治疗指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2020 Dec 22;142(25):e558-e631. doi: 10.1161/CIR.0000000000000937. Epub 2020 Nov 20.
7
Association of pulse rate with outcomes in heart failure with reduced ejection fraction: a retrospective cohort study.脉率与射血分数降低型心力衰竭结局的相关性:一项回顾性队列研究。
BMC Cardiovasc Disord. 2020 Feb 26;20(1):92. doi: 10.1186/s12872-020-01384-6.
8
Percutaneous Intramyocardial Septal Radiofrequency Ablation for Interventricular Septal Reduction: An Ovine Model with 1-Year Outcomes.经皮心肌间隔射频消融术用于室间隔减容:1年随访结果的绵羊模型
Cardiology. 2020;145(1):53-62. doi: 10.1159/000502973. Epub 2019 Nov 20.
9
Percutaneous intramyocardial septal radiofrequency ablation of hypertrophic obstructive cardiomyopathy: a novel minimally invasive treatment for reduction of outflow tract obstruction.经皮心肌间隔射频消融治疗肥厚性梗阻性心肌病:一种减少流出道梗阻的新型微创治疗方法。
EuroIntervention. 2018 Apr 6;13(18):e2112-e2113. doi: 10.4244/EIJ-D-17-00657.
10
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.超声心动图成人左心室容量和射血分数测量:美国超声心动图学会和欧洲心血管影像协会的更新建议。
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.